ClinicalTrials.govpublic full text
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
advanced cancer, anti pd-l1, anti 4-1bb, ox40 agonist, anti m-csf, tlr9 agonist, non-small cell lung cancer (nsclc), melanoma, squamous cell carcinoma of head and neck (scchn), triple negative breast cancer (tnbc), gastric cancer, small cell lung cancer (sclc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 880294
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.